295 related articles for article (PubMed ID: 27910712)
1. Development of a nanogel formulation for transdermal delivery of tenoxicam: a pharmacokinetic-pharmacodynamic modeling approach for quantitative prediction of skin absorption.
Elkomy MH; El Menshawe SF; Eid HM; Ali AM
Drug Dev Ind Pharm; 2017 Apr; 43(4):531-544. PubMed ID: 27910712
[TBL] [Abstract][Full Text] [Related]
2. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling.
Elkomy MH; Elmenshawe SF; Eid HM; Ali AM
Drug Deliv; 2016 Nov; 23(9):3294-3306. PubMed ID: 27066917
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam.
Khurana S; Bedi PM; Jain NK
Chem Phys Lipids; 2013; 175-176():65-72. PubMed ID: 23994283
[TBL] [Abstract][Full Text] [Related]
4. Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats.
Bawazeer S; El-Telbany DFA; Al-Sawahli MM; Zayed G; Keed AAA; Abdelaziz AE; Abdel-Naby DH
Drug Deliv; 2020 Dec; 27(1):1218-1230. PubMed ID: 32772730
[TBL] [Abstract][Full Text] [Related]
5. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
[TBL] [Abstract][Full Text] [Related]
6. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.
Al-Mahallawi AM; Abdelbary AA; Aburahma MH
Int J Pharm; 2015 May; 485(1-2):329-40. PubMed ID: 25796122
[TBL] [Abstract][Full Text] [Related]
7. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
[No Abstract] [Full Text] [Related]
8. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
Khurana S; Jain NK; Bedi PM
Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
[TBL] [Abstract][Full Text] [Related]
9. Enhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation.
Sadarani B; Majumdar A; Paradkar S; Mathur A; Sachdev S; Mohanty B; Chaudhari P
Biomed Pharmacother; 2019 Jun; 114():108770. PubMed ID: 30913494
[TBL] [Abstract][Full Text] [Related]
10. Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery.
Gönüllü Ü; Üner M; Yener G; Karaman EF; Aydoğmuş Z
Acta Pharm; 2015 Mar; 65(1):1-13. PubMed ID: 25781700
[TBL] [Abstract][Full Text] [Related]
11. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
12. Development, optimization, and characterization of a novel tea tree oil nanogel using response surface methodology.
Sinha P; Srivastava S; Mishra N; Singh DK; Luqman S; Chanda D; Yadav NP
Drug Dev Ind Pharm; 2016 Sep; 42(9):1434-45. PubMed ID: 26821208
[TBL] [Abstract][Full Text] [Related]
13. Sustained Anti-inflammatory Effect of Resveratrol-Phospholipid Complex Embedded Polymeric Patch.
Kalita B; Das MK; Sarma M; Deka A
AAPS PharmSciTech; 2017 Apr; 18(3):629-645. PubMed ID: 27173988
[TBL] [Abstract][Full Text] [Related]
14. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.
Hamishehkar H; Ghanbarzadeh S; Sepehran S; Javadzadeh Y; Adib ZM; Kouhsoltani M
Drug Dev Ind Pharm; 2016; 42(6):846-53. PubMed ID: 26154267
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies.
Bhaskar K; Anbu J; Ravichandiran V; Venkateswarlu V; Rao YM
Lipids Health Dis; 2009 Feb; 8():6. PubMed ID: 19243632
[TBL] [Abstract][Full Text] [Related]
16. Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment.
Garg V; Singh H; Bhatia A; Raza K; Singh SK; Singh B; Beg S
AAPS PharmSciTech; 2017 Jan; 18(1):58-71. PubMed ID: 26868380
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of formulated tenoxicam transdermal delivery systems.
Kim T; Kang E; Chun I; Gwak H
J Pharm Pharmacol; 2008 Jan; 60(1):135-8. PubMed ID: 18088513
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers.
Chen ZX; Li B; Liu T; Wang X; Zhu Y; Wang L; Wang XH; Niu X; Xiao Y; Sun Q
Eur J Pharm Sci; 2017 Mar; 99():240-245. PubMed ID: 28039091
[TBL] [Abstract][Full Text] [Related]
19. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
20. Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam.
Dasgupta S; Ray S; Dey S; Pal P; Mazumder B
Pharm Nanotechnol; 2017; 5(1):32-43. PubMed ID: 28948909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
